Health Care • Biotechnology: Laboratory Analytical Instruments
$62.00 ▲ +0.00
(0.00%)
MKT CAP: $9.45B • VOL: 1.50M
52W L $32 52W H $67
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$52
MEDIAN
$69
MEAN
$71
HIGH
$84
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE BRKR TAPE
BRKR // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $75.02 | $71.30 | 2025-02-14 | $56.42 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $78.12 | $73.16 | 2025-02-06 | $58.28 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $70.68 | $68.20 | 2025-01-29 | $59.52 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $63.24 | — | 2025-01-17 | $60.76 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $54.56 | $58.90 | 2025-01-09 | $55.18 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $73.78 | $64.48 | 2024-12-18 | $53.94 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $60.14 | $62.62 | 2024-12-04 | $57.66 | -4.3% | 48% | C |